Profile
Ralph M.
Sinibaldi held several positions in various companies, including Founding Vice President at AgraQuest, Inc., Vice President-Product Development at GenoSpectra, Inc. and Iris BioTechnologies, Inc., Chief Scientific Officer & Vice President at Cardigant Medical, Inc., and Vice President-Scientific Affairs at QIAGEN Operon, Inc. Prior to his career in the industry, he earned an undergraduate degree in 1970, a graduate degree in 1974, and a doctorate in 1978 from the University of Illinois and the University of Illinois College of Medicine.
Former positions of Ralph Sinibaldi
| Companies | Position | End |
|---|---|---|
Sandoz Corp.
 Sandoz Corp. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Corp. develops, produces, and markets medicines. | Corporate Officer/Principal | - |
Cardigant Medical, Inc.
 Cardigant Medical, Inc. BiotechnologyHealth Technology Cardigant Medical, Inc. operates as a development stage biotechnology company. The company focuses on the development of novel biologic compounds and methods for local delivery for the treatment of cardiovascular and peripheral vascular disease. It plans to treat atherosclerosis and plaque stabilization using targeted delivery of large molecule therapeutics based on high density lipoprotein targets. The company also focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes, carotid stenosis and aortic valve stenosis. Cardigant Medical was founded on April 17, 2009 by Jerett A. Creed and is headquartered in Manhattan Beach, CA. | Chief Tech/Sci/R&D Officer | - |
QIAGEN Operon, Inc.
 QIAGEN Operon, Inc. Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Operon, Inc. develops and sells DNA segments. The company is based in Alameda, CA. QIAGEN Operon was acquired by QIAGEN NV on June 29, 2000 for $117.57 million. | Chief Tech/Sci/R&D Officer | - |
AgraQuest, Inc.
 AgraQuest, Inc. Chemicals: AgriculturalProcess Industries AgraQuest, Inc. develops pesticides and provides best management services. The company was founded in 1995 and is headquartered in Research Triangle Park, NC. | Corporate Officer/Principal | - |
GenoSpectra, Inc.
 GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Training of Ralph Sinibaldi
| University of Illinois | Undergraduate Degree |
| University of Illinois College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Iris BioTechnologies, Inc.
 Iris BioTechnologies, Inc. Medical SpecialtiesHealth Technology Iris Biotechnologies, Inc. is life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications. The company was founded by Simon Chin on February 16, 1999 and is headquartered in Santa Clara, CA. | Health Technology |
GenoSpectra, Inc.
GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Health Technology |
AgraQuest, Inc.
AgraQuest, Inc. Chemicals: AgriculturalProcess Industries AgraQuest, Inc. develops pesticides and provides best management services. The company was founded in 1995 and is headquartered in Research Triangle Park, NC. | Process Industries |
QIAGEN Operon, Inc.
QIAGEN Operon, Inc. Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Operon, Inc. develops and sells DNA segments. The company is based in Alameda, CA. QIAGEN Operon was acquired by QIAGEN NV on June 29, 2000 for $117.57 million. | Health Technology |
Cardigant Medical, Inc.
Cardigant Medical, Inc. BiotechnologyHealth Technology Cardigant Medical, Inc. operates as a development stage biotechnology company. The company focuses on the development of novel biologic compounds and methods for local delivery for the treatment of cardiovascular and peripheral vascular disease. It plans to treat atherosclerosis and plaque stabilization using targeted delivery of large molecule therapeutics based on high density lipoprotein targets. The company also focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes, carotid stenosis and aortic valve stenosis. Cardigant Medical was founded on April 17, 2009 by Jerett A. Creed and is headquartered in Manhattan Beach, CA. | Health Technology |
Sandoz Corp.
Sandoz Corp. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Corp. develops, produces, and markets medicines. | Health Technology |
- Stock Market
- Insiders
- Ralph Sinibaldi
